Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
9.74
+0.19 (1.99%)
At close: Jun 27, 2025, 4:00 PM
9.51
-0.23 (-2.36%)
After-hours: Jun 27, 2025, 7:14 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023
Period Ending
Dec '24 Dec '23
Vonoprazan
55.25M
Log In
Vonoprazan Growth
8001.47%
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023
Period Ending
Dec '24 Dec '23
United States
55.25M
Log In
United States Growth
8001.47%
Log In